Bio Intelligence Suite

    Life Sciences
    Bio Intelligence

    The AI Foundation answers "is your AI governed?"

    The Bio Intelligence suite answers "what can your AI discover?"

    Multi-modal wet-lab data ingestion, AI-powered biomarker discovery, predictive regulatory intelligence, and therapeutic area modules — all running on sovereign, governed infrastructure.

    Core Capabilities

    Three pillars that transform BioCompute from governance infrastructure into an irreplaceable intelligence platform.

    Multi-Modal Wet-Lab Data Ingestion

    A modality-agnostic pipeline for ingesting and quantifying complex biological data at single-cell resolution.

    Sequencing: FASTQ, BAM, SAM, CRAM, VCF, BCF
    Proteomics: mzML, mzXML, mgf, mass spectrometry
    Imaging: TIFF, OME-TIFF, DICOM, SVS (microscopy, pathology)
    Clinical: HL7 FHIR, CSV/TSV, JSON, XML, Parquet
    Native intoDNA STRIDE® integration for DNA damage response

    AI-Powered Biomarker Discovery

    Private AI models running on sovereign infrastructure. The AI doesn't just analyze — it discovers.

    Automated cell counting and classification at single-cell resolution
    Biomarker quantification with reproducibility guarantees
    Patient stratification signal detection from multi-modal data
    Mechanism of Action (MoA) correlation across datasets

    Predictive Regulatory Intelligence

    AI that understands regulatory requirements and proactively identifies compliance gaps before they become submission blockers.

    Regulatory change monitoring (FDA, EMA, Health Canada, EU AI Act)
    Gap analysis: compare evidence against submission requirements
    Submission readiness scoring with remediation recommendations
    Cross-jurisdiction mapping (file once, satisfy multiple regimes)

    Therapeutic Area Modules

    Domain-specific AI for the most demanding therapeutic areas. Oncology first — leveraging AstraZeneca-validated STRIDE® DDR integration.

    Oncology

    P0 — Q4 2026

    DDR pathway analysis, companion diagnostics, immunotherapy response prediction

    Differentiation: Native STRIDE® DDR integration (AstraZeneca validated)

    Neurodegeneration

    2027

    Protein aggregation studies, neuroimaging analysis, clinical trial endpoints

    Differentiation: Multi-modal imaging + clinical data correlation

    Immunology

    2027

    Cytokine profiling, immune cell phenotyping, inflammatory pathway analysis

    Differentiation: High-plex proteomics at single-cell resolution

    Reproductive Health

    2027

    Fertility biomarkers, prenatal screening, embryo assessment

    Differentiation: HIPAA + GDPR dual-compliance evidence generation

    Cardiovascular

    2027+

    Cardiac biomarkers, imaging analysis, risk stratification

    Differentiation: Real-world evidence integration with sovereign AI

    Built on the AI Foundation

    Every Discovery is Governed

    The Bio Intelligence suite runs on the AI Foundation. Every biomarker discovery, every data ingestion, every predictive model — automatically secured by the AI Gateway, traced by the Evidence Engine, and packaged into submission-ready Evidence Books.

    AI GatewayAgentic HubEvidence EngineCompliance ManagerEvidence Books